Physician profile
Kyler Dean Thomas
NPI 1699180711
$1,953.99
in general payments reported to CMS, 2019-2025
16 companies · $559 in 2025
The $559 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $128 · 2021: $184 · 2022: $72.04 · 2023: $400 · 2024: $450 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,409.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,233.12 | 2020-2025 | Grafix Pl, Stravix Pl, Stravix |
| Convatec INC. | $133.77 | 2023 | |
| Stryker Corporation | $96.63 | 2019 | |
| Organogenesis INC. | $91.79 | 2020-2021 | |
| Horizon Therapeutics Plc | $77.82 | 2020-2023 | Krystexxa |
| Arthrosurface Incorporated | $43.81 | 2019 | |
| Abbvie INC. | $42.95 | 2021-2023 | Dalvance |
| Paratek Pharmaceuticals, INC. | $42.90 | 2022-2025 | Nuzyra |
| Medline Industries LP | $37.56 | 2025 | |
| Djo, LLC | $35.62 | 2025 | Cmf |
| Medtronic Vascular, INC. | $30.91 | 2020 | |
| Aroa Biosurgery Incorporated | $20.15 | 2019 | |
| Amgen INC. | $19.70 | 2025 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $17.47 | 2023 | Seglentis |
| Sanara Medtech INC. | $16.45 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $13.34 | 2023 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyler Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.